Merck (MRK) P/S (1999 - 2026)
Merck (MRK) P/S from Nov 1, 1999 to Jul 20, 2026. The TTM Merck (MRK) P/S is 4.46. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Merck (MRK)
| Year | P/S | Change |
|---|---|---|
| 2026 | 4.46 | +15.75% |
| 2025 | 3.85 | +2.83% |
| 2024 | 3.75 | -15.75% |
| 2023 | 4.45 | -2.15% |
| 2022 | 4.55 | +19.70% |
| 2021 | 3.80 | -20.10% |
| 2020 | 4.75 | -16.21% |
| 2019 | 5.67 | +23.66% |
| 2018 | 4.59 | +88.24% |
| 2017 | 2.44 | -123.91% |
| 2012 | -10.20 | -318.58% |
| 2011 | 4.66 | +102.67% |
| 2010 | 2.30 | -21.83% |
| 2009 | 2.94 | +132.68% |
| 2008 | 1.27 | -36.36% |
| 2007 | 1.99 | +33.28% |
| 2006 | 1.49 | +37.06% |
| 2005 | 1.09 | -1.03% |
| 2004 | 1.10 | -30.43% |
| 2003 | 1.58 | -18.39% |
| 2002 | 1.94 | -3.72% |
| 2001 | 2.01 | -37.20% |
| 2000 | 3.20 | +39.35% |
| 1999 | 2.30 | N/A |
Comparison Merck (MRK) P/S with competitors
Merck (MRK) P/S is 4.46.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -87.11% |
| NVO | Novo Nordisk | 0.66 | -85.16% |
| GRFS | Grifols SA | 0.67 | -84.96% |
| AMRN | Amarin Corp | 1.39 | -68.85% |
| SCLX | Scilex Holding Company | 1.92 | -57.08% |
| SNY | Sanofi | 2.18 | -51.07% |
| PFE | Pfizer Inc | 2.18 | -51.07% |
| BMY | Bristol-Myers Squibb Company | 2.40 | -46.23% |
| BIIB | Biogen Inc | 2.93 | -34.33% |
| GSK | GSK Plc | 3.22 | -27.74% |
| AZN | Astrazeneca plc | 4.58 | +2.77% |
| NVS | Novartis AG | 5.07 | +13.64% |
| AMGN | AMGEN Inc | 5.15 | +15.43% |
| GILD | Gilead Sciences Inc | 5.43 | +21.70% |
| JNJ | Johnson & Johnson | 6.34 | +42.10% |
| ABBV | Abbvie Inc | 7.15 | +60.26% |
| LLY | Lilly(Eli) & Company | 14.28 | +220.06% |